WHO sets goals for future long-acting TB injections

WHO sets goals for future long-acting TB injections

Updated at: October 30, 2026 at 01:08 AM

Taking medicine every day for months can be difficult. WHOโ€™s October 28 update describes development goals for long-acting injectable regimens against tuberculosis. The document guides future research; it does not announce that these proposed regimens are already available for routine use.

nounresearch

The profiles distinguish prevention from treatment of TB disease. For preventive treatment, the goal is a complete course delivered through one injection at one encounter. That is a design target, not a direction for patients to change existing medicines.

nounprevention

For TB disease, the profile aims for a regimen lasting no more than four months, with three or fewer dosing encounters. The number of visits and the treatment duration are separate characteristics that developers must consider together.

nounduration

Convenience is not the only requirement. The profiles seek efficacy and safety at least as good as current oral regimens, small injection volumes and delivery by trained health workers. They also call for products that do not require a cold chain.

nounrequirement
nounefficacy

Each characteristic has a minimum requirement and an optimal target. The framework also considers costs, access and the burden on health services. Fewer patient dosing encounters still require a system capable of delivering them reliably.

nounrequirement

Patient choice remains important. WHO says work on better oral regimens should continue alongside injectable development. The purpose is to create useful alternatives, rather than assume that every person would prefer an injection.

nounchoice
๐ŸŽ‰

End of article

You read 6 focus sentences.

Challenge Mode

Comprehension Questions

What did WHO publish?

โœ“

Correct Choice

Development goals for future regimens

What is the preventive-treatment target?

โœ“

Correct Choice

One injection at one encounter

What duration is targeted for TB disease treatment?

โœ“

Correct Choice

No more than four months

How should safety and efficacy compare with current oral regimens?

โœ“

Correct Choice

At least as good

What should happen to oral-regimen research?

โœ“

Correct Choice

Continue alongside injection research

Ringoo Icon

Learn faster with Ringoo apps

Trace your learning progress and get real-time feedback with interactive exercises.